Researchers identify key protein balancing gut immunity and inflammation
View as a Web Page
News Medical
 
  Gastroenterology Gastroenterology logo  
  The latest gastroenterology‎ news from News Medical  
 Study links chronic xanthan gum consumption to colon inflammationStudy links chronic xanthan gum consumption to colon inflammation
 
Xanthan gum is found almost everywhere. This food additive has thickening, stabilizing, and gelling properties and is one of the most widely used by the food industry to adjust the consistency of ice cream, yogurt, cakes, sauces, and gluten-free pasta.
 
 
 Researchers identify key protein balancing gut immunity and inflammationResearchers identify key protein balancing gut immunity and inflammation
 
A protein produced by gut immune cells orchestrates both immune protection against pathogens and immune tolerance of gut bacteria, according to a study led by Weill Cornell Medicine investigators.
 
   Endometriosis affects multiple body systems beyond pelvic painEndometriosis affects multiple body systems beyond pelvic pain
 
Migraines, digestive problems, anxiety, and depression can be part of endometriosis, although they are often interpreted as separate conditions.
 
   Gut immune cells help prevent severe salmonella infectionsGut immune cells help prevent severe salmonella infections
 
Widely recognized as the face of food poisoning, salmonella bacteria lurk in raw meat and poultry, on pets and in unpasteurized dairy products.
 
   Six-gene signature predicts colorectal cancer recurrence after liver metastasesSix-gene signature predicts colorectal cancer recurrence after liver metastases
 
Researchers at The University of Texas MD Anderson Cancer Center identified a six-gene signature in microscopic colorectal cancer (CRC) liver metastases that may help predict recurrence after treatment.
 
 New biological feedback loop helps the immune system attack colorectal cancers
 
New biological feedback loop helps the immune system attack colorectal cancersA subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more visible to the immune system than others.
 
 
 New consensus outlines best practices for obesity medications
 
New consensus outlines best practices for obesity medicationsObesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding use of obesity drugs for weight loss treatment.
 
 
 Genetic research reveals surprising metabolic pathway for irritable bowel syndrome
 
Genetic research reveals surprising metabolic pathway for irritable bowel syndromeIrritable bowel syndrome (IBS) is a common condition that affects more than 10% of the general population, causing recurrent abdominal pain, bloating, constipation and diarrhea.
 
 
 High-risk emergency surgery reduces healthy days at home for seniors
 
High-risk emergency surgery reduces healthy days at home for seniorsOlder adults who undergo high-risk emergency general surgery spend significantly fewer days living independently at home after surgery than those undergoing lower-risk procedures, according to a study published in the Journal of the American College of Surgeons (JACS).
 
 
 Setmelanotide shows promise for hypothalamic obesity after brain tumors
 
Setmelanotide shows promise for hypothalamic obesity after brain tumorsA new therapy helps achieve a healthier BMI in people whose weight has become dysregulated following treatment for a brain tumor, a clinical trial has found.
 
 
 Sustainable oyster meat extract may reduce human intestinal inflammation
 
Sustainable oyster meat extract may reduce human intestinal inflammationOngoing research provides evidence that readily-available and sustainable oyster meat extract may have powerful anti-inflammatory effects on human intestinal cells.
 
 
 Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations
 
Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populationsA network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.
 
 
 AGA launches AI-powered virtual assistant for gastroenterology and hepatology care
 
AGA launches AI-powered virtual assistant for gastroenterology and hepatology careThe American Gastroenterological Association (AGA) today announced the launch of Nigel, an artificial intelligence (AI)-powered virtual assistant developed exclusively for gastroenterology and hepatology.
 
 
 Study: Bariatric surgery is safe, effective for obese adolescents and young adults
 
Study: Bariatric surgery is safe, effective for obese adolescents and young adultsA new study from researchers at LSU's Pennington Biomedical Research Center, FMOL Health | Our Lady of the Lake Regional Medical Center and Metamor Institute demonstrates that metabolic and bariatric surgery can be delivered safely and effectively for adolescents and young adults living with severe obesity, offering promising improvements in weight loss and obesity-related health conditions.
 
 
 Infectious disease expert explains who faces the highest risk from cyclosporiasis
 
Infectious disease expert explains who faces the highest risk from cyclosporiasisPeople across the United States are taking a closer look at their lettuce and leafy greens this summer thanks to an outbreak of cyclosporiasis, a gastrointestinal illness that causes several symptoms, the most notable being severe, watery diarrhea.
 
 
 Off-the-shelf CAR T therapy targets treatment-resistant systemic sclerosis
 
Off-the-shelf CAR T therapy targets treatment-resistant systemic sclerosisToday at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.
 
 
 Mcmaster researchers develop targeted phage therapy for inflammatory bowel disease
 
Mcmaster researchers develop targeted phage therapy for inflammatory bowel diseaseA research team at McMaster University has developed a targeted approach to treating inflammatory bowel disease (IBD) using bacteriophages, viruses that infect specific bacteria, to disarm harmful microbes without disrupting the broader gut ecosystem.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026